Cargando…

Recombinant Human Growth Hormone Therapy for Childhood Trichorhinophalangeal Syndrome Type I: A Case Report

Trichorhinophalangeal syndrome type I (TRPS I; MIM 190350) is a rare autosomal dominant disorder of congenital malformations due to variants of the gene TRPS1. We reported on an 11-year-old Chinese boy with TRPS I. He had typical clinical findings, including sparse hair, a bulbous nose, a long philt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Dan, Zhao, Jia, Xia, Fang-Ling, Zou, Chao-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600025/ https://www.ncbi.nlm.nih.gov/pubmed/36291383 http://dx.doi.org/10.3390/children9101447

Ejemplares similares

Trichorhinophalangeal Syndrome
por: Vaccaro, Mario, et al.
Publicado: (2017)

Clinical, biochemical, and genetic analysis of two Korean patients with Trichorhinophalangeal syndrome type I and growth hormone deficiency
por: Sohn, Young Bae, et al.
Publicado: (2013)

Treatment of Hair Loss in the Trichorhinophalangeal Syndrome
por: Choi, Mi Soo, et al.
Publicado: (2018)

Novel Frameshift Mutation in TRPS1 in a Ukrainian Patient with Trichorhinophalangeal Syndrome Type I
por: Ovcharenko, Yuliya, et al.
Publicado: (2013)

Comprehensive Transcriptome Profiling of Balding and Non-Balding Scalps in Trichorhinophalangeal Syndrome Type I Patient
por: Kim, Yun-Ji, et al.
Publicado: (2017)

An intragenic duplication of TRPS1 leading to abnormal transcripts and causing trichorhinophalangeal syndrome type I
por: Zepeda-Mendoza, Cinthya J., et al.
Publicado: (2019)

Trichorhinophalangeal syndrome type 1: A case report with literature review
por: Candamourty, Ramesh, et al.
Publicado: (2012)

Trichorhinophalangeal Syndrome Type I: A Patient with Two Novel and Different Mutations in the TRPS1 Gene
por: Dias, Catarina, et al.
Publicado: (2013)

Dysmorphic Short Stature: Radiological Diagnosis of Trichorhinophalangeal Syndrome
por: Nicolescu, Corina Ramona, et al.
Publicado: (2018)

The Clinical and Molecular Spectrum of Trichorhinophalangeal Syndrome Types I and II in a Turkish Cohort Involving 22 Patients
por: Güneş, Nilay, et al.
Publicado: (2023)

A Missense Mutation in TRPS1 in a Family with Trichorhinophalangeal Syndrome Type III Accompanied by Ankylosing Spondylitis
por: Fang, Xiaokai, et al.
Publicado: (2022)

Urgent Airway Management and Postoperative Complications in a Patient with Trichorhinophalangeal Syndrome
por: Esmaeilzadeh, Sarvie, et al.
Publicado: (2020)

An early diagnosis of trichorhinophalangeal syndrome type 1: a case report and a review of literature
por: Trippella, Giulia, et al.
Publicado: (2018)

A novel TRPS1 gene mutation causing trichorhinophalangeal syndrome with growth hormone responsive short stature: a case report and review of the literature
por: Merjaneh, Lina, et al.
Publicado: (2014)

High grade osteosarcoma on a background of trichorhinophalangeal syndrome: A family perspective
por: Evans, Scott, et al.
Publicado: (2013)

Annular pancreas in Trichorhinophalangeal syndrome type II with 8q23.3-q24.12 interstitial deletion
por: Li, Qi, et al.
Publicado: (2015)

Generalized Hypertrichosis After 5% Minoxidil Solution in Trichorhinophalangeal Syndrome: A Case Report and Review of the Literatures
por: Shin, Bong Seok, et al.
Publicado: (2023)

ODP408 Elevated DHEAS and Acute Hair Loss in an Adult Male with Trichorhinophalangeal Syndrome Type 1: a Case of Male PCOS
por: Zenno, Anna, et al.
Publicado: (2022)

Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome
por: Gao, Ying, et al.
Publicado: (2023)

Risk of cancer in patients treated with recombinant human growth hormone in childhood
por: Cianfarani, Stefano
Publicado: (2019)

An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4
por: Selenti, Nikoletta, et al.
Publicado: (2015)

Erratum to: An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4
por: Selenti, Nikoletta, et al.
Publicado: (2015)

Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
por: Hou, Ling, et al.
Publicado: (2015)

Recombinant human growth hormone in the treatment of Turner syndrome
por: Spiliotis, Bessie E
Publicado: (2008)

The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency
por: Yao, Qian, et al.
Publicado: (2021)

Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome
por: Gnacińska, Maria, et al.
Publicado: (2022)

Metabolomic Differential Compounds Reflecting the Clinical Efficacy of Polyethylene Glycol Recombinant Human Growth Hormone in the Treatment of Childhood Growth Hormone Deficiency
por: Li, Ji, et al.
Publicado: (2022)

Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency
por: Kim, Ja Hye, et al.
Publicado: (2014)

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
por: Deal, Cheri L., et al.
Publicado: (2013)

Effect of Vitamin D Combined with Recombinant Human Growth Hormone in Children with Growth Hormone Deficiency
por: Wang, Pingping, et al.
Publicado: (2022)

Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency
por: Lee, Yun Jeong, et al.
Publicado: (2022)

Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood
por: Sommer, Grit, et al.
Publicado: (2015)

Recombinant growth hormone therapy in a girl with costello syndrome: a 4-year observation
por: Blachowska, Ewa, et al.
Publicado: (2016)

Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency
por: Gahlot, Monita, et al.
Publicado: (2019)

Association Between Recombinant Growth Hormone Therapy and All-Cause Mortality and Cancer Risk in Childhood: Systematic Review and Meta-Analysis
por: He, Mengyang, et al.
Publicado: (2022)

Hypertrophic scars in a patient with Turner's syndrome treated with recombinant growth hormone
por: Kędzia, Andrzej, et al.
Publicado: (2014)

Bone age is the best predictor of growth response to recombinant human growth hormone in Turner’s syndrome
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2010)

Childhood growth hormone treatment in women with Turner syndrome - benefits and adverse effects
por: Irzyniec, Tomasz, et al.
Publicado: (2019)

Effects of recombinant human growth hormone therapy on carbohydrate, lipid and protein metabolisms of children with Turner syndrome
por: Qi, Weibin, et al.
Publicado: (2014)

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
por: Jeong, Insook, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bv9rcl7u7eqeb70jsos769oogl